Old Web
English
Sign In
Acemap
>
authorDetail
>
Chris Resburg
Chris Resburg
Acorda Therapeutics, Inc.
Medicine
Physical therapy
Placebo
Parkinson's disease
Antipsychotic
4
Papers
105
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 3 Study of Tozadenant (TOZ-PD) as a Maintenance Therapy for Patients With Parkinson’s Disease Experiencing Motor Fluctuations: Characterization of Study Population (P2.045)
2018
Neurology
Karl Kieburtz
C. Warren Olanow
Jayshree Krishnaswami
Chris Resburg
Fred Kerwood
Andrew Glass
Christopher Kenney
Show All
Source
Cite
Save
Citations (2)
Tozadenant (SYN115) in patients with Parkinson’s disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
2014
Robert A. Hauser
C. Warren Olanow
Karl Kieburtz
Emmanuelle Pourcher
Any Docu-Axelerad
Mark F. Lew
Olexandr Kozyolkin
Ann Neale
Chris Resburg
Uwe Meya
Christopher Kenney
Stephen Bandak
Show All
Source
Cite
Save
Citations (0)
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
2014
Lancet Neurology
Robert A. Hauser
C. Warren Olanow
Karl Kieburtz
Emmanuelle Pourcher
Any Docu-Axelerad
Mark F. Lew
Olexandr Kozyolkin
Ann Neale
Chris Resburg
Uwe Meya
Christopher Kenney
Stephen Bandak
Show All
Source
Cite
Save
Citations (90)
A phase 2, placebo-controlled, randomized, double-blind trial of tozadenant (Syn-115) in patients with Parkinson's disease with wearing-off fluctuations on levodopa
2013
Journal of the Neurological Sciences
Robert A. Hauser
C.W Olanow
Karl Kieburtz
Ann Neale
Chris Resburg
Uwe Meya
S.I. Bankak
Show All
Source
Cite
Save
Citations (13)
1